MedPath

AUSTrian Randomized Interventional Study on Dialysis Accesses

Not Applicable
Conditions
End Stage Renal Disease
Shunt Malfunction
Catheter Infection
Interventions
Device: Arteriovenous Fistula
Device: Tunneled Cuffed Catheter
Registration Number
NCT03764358
Lead Sponsor
Medical University of Vienna
Brief Summary

Patients with diagnosed end stage renal disease and indication for chronic dialysis rely on a well-functioning access for dialysis. The KDOQI Guidelines For Vascular Access follows a "fistula first" approach for every patient, whenever possible. Thus, every patient, regardless of age, clinical state and co-morbidities an arteriovenous fistula should be preferred over a tunneled cuffed catheter (TCC). These recommendations are based on retrospective and register studies. There have been no prospective studies in this subject so far. In addition, most of the collected data refers to patients of all ages, regardless of their comorbidities and general clinical state. In this study, we address differences between two dialysis vascular access types in elderly or frail patients. We will compare TCCs with arteriovenous fistulas in the selected population consisting of elderly patients over 60 years of age or those with a Charlson Comorbidity Index \>6 independent of age. In our hypothesis TCCs will be superior to arteriovenous fistulas in this population regarding the examined end-points.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
220
Inclusion Criteria
  • Age of 60 and higher
  • CCI Score >6 when under 60 years
  • Patients with CKD G5 A1-3 with indication for hemodialysis
  • Stable clinical condition
  • Eligibility for both arteriovenous fistula on the upper extremitiesandTCC
  • Availability for follow-up.
  • Written informed consent.
Read More
Exclusion Criteria
  • Uncontrolled infection at screening and/or CRP >5 mg/dl (normal <0.5 mg/dl) at screening.
  • Poor general condition of health or malignancy not in remission at screening
  • Major surgery within 12 weeks before screening.
  • Pre-existent vascular access.
  • Patient not eligible for any one of the vascular access options.
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Arteriovenous fistulaArteriovenous Fistula-
Tunneled Cuffed CatheterTunneled Cuffed Catheter-
Primary Outcome Measures
NameTimeMethod
Composite primary end-point of any access related complicationFrom placement of vascular access through study completion, an average of 3 years.

Loss of access, catheter related bloodstream infection/shunt infection and/or thrombosis

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Department of Medicine III, Devision of Nephrology and Dialysis, Medical University of Vienna

🇦🇹

Vienna, Austria

© Copyright 2025. All Rights Reserved by MedPath